⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001959158

Kim Bobae

Reports to the SEC for 1 company · MORRISTOWN, NJ

Transactions

6

Companies

1

Filings

2

CIK

0001959158

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-07	Bellerophon Therapeutics, Inc.Stock Options (Right to Buy)A Award	VP Reg. Affairs & Quality	AAward	−50K sh	—	—	50,000
2023-05-18	Bellerophon Therapeutics, Inc.M Exercise/Conversion	VP Reg. Affairs & Quality	MExercise/Conversion	+266 sh	$7.35	+$1,955.1	1,723
2023-05-18	Bellerophon Therapeutics, Inc.M Exercise/Conversion	VP Reg. Affairs & Quality	MExercise/Conversion	+1,022 sh	$7.50	+$7,665	1,723
2023-05-18	Bellerophon Therapeutics, Inc.S Sale	VP Reg. Affairs & Quality	SSale	−9,455 sh	$10.00	−$94.6K	1,723
2023-05-18	Bellerophon Therapeutics, Inc.Stock Options (Right to Buy)M Exercise/Conversion	VP Reg. Affairs & Quality	MExercise/Conversion	−266 sh	—	—	0
2023-05-18	Bellerophon Therapeutics, Inc.Stock Options (Right to Buy)M Exercise/Conversion	VP Reg. Affairs & Quality	MExercise/Conversion	−1,022 sh	—	—	144

Recent filings

2

Accepted (ET)
Jun 94
Kim Bobae0001104659-23-069907
SEC(opens sec.gov)
May 224
Kim Bobae0001104659-23-063263
SEC(opens sec.gov)

Companies

1

Bellerophon Therapeutics, Inc.VP Reg. Affairs & Quality

Address

44 PROSPECT ST. APT. 536

MORRISTOWN, NJ, 07960